Search
18/09/2025
Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation
Bosma, KJ, Burns, KEA, Martin, CM, Skrobik, Y, Corts, JM, Mulligan, S, Lafreniere-Roula, M, Thorpe, KE, Montero, JCS, Chorro, IM, Rodrguez-Farr, N, Butler, R, Bentall, T, Beduneau, G, Enguerrand, P, Santos, M, Piraino, T, Spadaro, S, Montanaro, F, Basmaji, J, Campbell, E, Mercat, A, Beloncle, FM, Carteaux, G, Maraffi, T, Charbonney, E, Lecronier, M, Dres, M, Arabi, YM, Amaral, ACKB, Marinoff, N, Adhikari, NKJ, Geagea, A, Shin, P, Vaporidi, K, Kondili, E, Shahin, J, Campisi, J, Rodriguez, PO, Setten, M, Goligher, EC, Ferguson, ND, Fanelli, V, Ferreyra, G, Lellouche, F, Sibley, S, Brochard, L. Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation. NEW ENGLAND JOURNAL OF MEDICINE. 2025; 393(11)DOI:10.1056/NEJMoa2505708. PMID:40513024. IF:78.500(Q1/1D).
18/09/2025
Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes
Milad, C, Viñals, C, Perea, V, Seres-Noriega, T, Blanco-Carrasco, A, Vinagre, I, Claro, M, Solà, C, Mesa, A, Ayala, D, Conget, I, Gimenez, M, Amor, AJ. Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70088. PMID:40965235. IF:6.000(Q1/2D).
18/09/2025
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases
Valero-Martinez, C, Pardines-Ortiz, M, Montes, N, Dauden, E, Fernández-Gutierrez, B, Garcia-Planella, E, Garcia, FG, Gratacós, J, Perez-Venegas, JJ, Julia, A, Marsal, S, Lamana, A, Garcia-Vicuña, R, González-Alvaro, I, Triguero-Martinez, A. Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(18)DOI:10.3390/ijms26189087. PMID:41009653. IF:4.900(Q1/3D).
17/09/2025
Interobserver agreement of the Taulí-pT1 classification in rectal pT1 adenocarcinoma
Gener-Jorge, C, Piñas, JCF, Garcia, ABM, Rivera, DSM, Casalots, A, Nonell, A, Espina, B, Caro-Tarragó, A, Serra-Aracil, X. Interobserver agreement of the Taulí-pT1 classification in rectal pT1 adenocarcinoma. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2025; 40(1)DOI:10.1007/s00384-025-04996-6. PMID:40957973. IF:2.300(Q2/3D).
15/09/2025
Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV
Quesada-López, T, Mestres-Arenas, A, Domingo, P, Prieto, P, Mur, I, Pérez, JAH, Guimaraes, MP, Villarroya, J, Gutiérrez, MD, Mateo, MG, Domingo, JC, Planavila, A, Villarroya, F, Giralt, M, Cereijo, R. Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV. EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; 1003DOI:10.1016/j.ejphar.2025.177996. PMID:40714072. IF:4.700(Q1/2D).
14/09/2025
Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels
Delgado-Arija, M, Carmena, MDGC, Martínez-Selles, M, Guerra, JM, Valdivielso, S, González-Juanatey, JR, Rivas-Lasarte, M, Roselló-Lleti, E, Perez-Villacastin, J, Carrasquer, A, Matute-Blanco, L, Grande-Trillo, A, Crespo-Leiro, MG, Delgado, JF, Martinez-Dolz, L. Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels. Clinical and Translational Medicine. 2025; 15(9)DOI:10.1002/ctm2.70398. PMID:40947803. IF:6.800(Q1/2D).
12/09/2025
A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia
Alonso-Ojembarrena, A, Poindexter, B, Aleem, S, Healy, H, Aguar-Carrascosa, M, Moliner-Calderón, E, Serrano-Martin, MD, Arroyo, R, Vento, M. A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia. Frontiers in Pediatrics. 2025; 13DOI:10.3389/fped.2025.1639573. PMID:41018057. IF:2.000(Q2/4D).
10/09/2025
Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline
Park, HS, del Campo, PD, Plana, MN, La Borda, JPY, Guerra-Rodriguez, M, Moreno, M, Cañete, JD. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1621313. PMID:41001393. IF:3.000(Q1/2D).
09/09/2025
Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results
Rubio-Briones, J, Borque-Fernando, A, Escaño, LME, Wong, A, Cascales, AG, Gómez, EG, Fabra, JMG, Sanguedolce, F, Gomez-Veiga, F, González, PAL, Bello, AP, Garcia, NR, Semper, MM, Novo, JFS, Hajianfar, R, Ciutat, LLF, Alfaro, AG, Ojeda, JMD, Ariño, AB, Dorado, CQ, Iriarte, AL, Fadrique, GG, Bachs, JMG, Barreras, SG, Costa, YP, Cabo, AV, Aliaga, MR, Perez, FC, Servián, P, Bortoló, JMC, Delgado, MS, de Ledesma, JMR, Rodriguez, CS, Abal, VC, Martinez, YEH, Imbroda, BH, Dolezal, P, Frau, JG, Llorente, PM, Jimenez, JM, Uribe, JSS, Ruiz, CBC, Reyes, A, Aparicio, TF, Rodriguez, JG, Sole, MC, Segui, AG, Bru, JJP, de Castro, JM, Moreno, AM, Suárez, JLM. Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results. Cancer Medicine. 2025; 14(17)DOI:10.1002/cam4.71173. PMID:40926355. IF:3.100(Q2/5D).
09/09/2025
Socioeconomic status and equity among patients with cardiogenic shock
Marcos-Mangas, M, López-Sobrino, T, Ariza-Sole, A, Rueda-Sobella, F, Sanz-Girgas, E, Aboal, J, Pastor, P, Buera, I, Sionis, A, Andrea, R, Rodriguez-López, J, Tomas, C, Bañeras, J, Llaó, I, Sánchez-Salado, JC, Garcia-Garcia, C. Socioeconomic status and equity among patients with cardiogenic shock. Frontiers in Cardiovascular Medicine. 2025; 12DOI:10.3389/fcvm.2025.1597225. PMID:40994919. IF:2.900(Q2/4D).
03/09/2025
Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change
Páez-Espinosa, EV, Sosa-Guzmán, DM, Buitrón-Andrade, LR, Dávila-Jumbo, N, Cáceres-Ruiz, MI, Robalino-Flores, VF, Mato-Matute, E. Morbidity and Mortality Profile of Leishmaniasis in an Andean Region of Ecuador in the Context of Climate Change. Tropical Medicine and Infectious Disease. 2025; 10(9)DOI:10.3390/tropicalmed10090254. PMID:41003564. IF:2.600(Q1/1D).
02/09/2025
An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease
Fortea, J, Ferrer-Picón, E. An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease. Expert Review of Neurotherapeutics. 2025; 25(9)DOI:10.1080/14737175.2025.2527211. PMID:40600688. IF:3.400(Q2/3D).
02/09/2025
Propofol-based versus sevoflurane-based anaesthesia for deceased donor kidney transplantation: the VAPOR-2 study protocol for an international multicentre randomised controlled trial
Huisman, GJJ, Berger, SP, Thyrrestrup, PS, Hausken, J, Veelo, DP, Guirado, L, Pol, R, Jensen, LL, Tonnessen, TI, Bemelman, FJ, Facundo, C, Tamasi, K, Lunter, G, Jespersen, B, Leuvenink, HGD, Struys, MMRF, Nieuwenhuijs-Moeke, GJ. Propofol-based versus sevoflurane-based anaesthesia for deceased donor kidney transplantation: the VAPOR-2 study protocol for an international multicentre randomised controlled trial. BMJ Open. 2025; 15(9)DOI:10.1136/bmjopen-2025-098965. PMID:40897490. IF:2.300(Q2/3D).
01/09/2025
European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance)
de Sousa, DA, Zietz, A, Zedde, M, Katsanos, AH, Li, LX, Marti-Fabregas, J, Nolte, CH, Podlasek, A, Poli, S, Purrucker, J, Roaldsen, MB, Schellinger, PD, Strbian, D, Tsivgoulis, G, Tsokani, S, Veroniki, AA, Quinn, TJ. European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance). European Stroke Journal. 2025; 10(3)DOI:10.1177/23969873251316430. PMID:39904756. IF:4.500(Q1/2D).
01/09/2025
282nd ENMC international workshop-standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands
Iammarino, MA, Alonso-Perez, J, Stojkovic, T, Pegoraro, E, Lowes, L, Diaz-Manera, J. 282nd ENMC international workshop-standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands. NEUROMUSCULAR DISORDERS. 2025; 54DOI:10.1016/j.nmd.2025.106212. PMID:40997622. IF:2.800(Q2/5D).
01/09/2025
Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape
Querol, L, Rinaldi, S, Borsi, A, Boggia, GM, de Courcy, J, Taylor, Y, Wright, J, Karmous, W, Noel, W, Gary, C, zu Hörste, GM. Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:10.1111/jns.70047. PMID:40826893. IF:3.200(Q2/4D).
01/09/2025
Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain
de Frutos, F, Herrador, L, Peiró-Aventin, B, Eiros, R, Freire, JL, Zorio, E, Carbayo, A, Llongueras-Espi, P, Garcia-Alvarez, A, Ripoll-Vera, T, Macias, R, Vilches, S, Ruiz-Bustillo, S, Arana-Achaga, X, Ordás, JG, Piqueras-Flores, J, Ruiz-Cueto, M, Casasnovas, C, Tirón, C, Rojas-Garcia, R, Sevilla, T, Rodriguez-Palomares, JF, González-López, E, Villacorta, E, Garcia-Pavia, P, González-Costello, J. Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(9)DOI:10.1016/j.rec.2024.12.012. PMID:39827963. IF:4.900(Q1/2D).
01/09/2025
Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy
Lopes, S, Fonseca, V, Pascual-Sedano, B, Simoes, R, Varanda, S, Pagonabarraga, J, Campolongo, A, Rodrigues, M. Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. PARKINSONISM & RELATED DISORDERS. 2025; 138DOI:10.1016/j.parkreldis.2025.107966. PMID:40763399. IF:3.400(Q2/3D).
01/09/2025
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
Veszelei, I, Godman, B, Aaltonen, K, Selke, GW, Garuoliene, K, Cangini, A, Kurdi, A, Rodrigues, AT, Pontes, C, Torre, C, Lunghi, C, Burton, E, Poplavska, E, Jónsdóttir, F, Petrova, G, Langner, I, Iaru, I, Odnoletkova, I, Slaby, J, Gvozdanovic, K, Saastamoinen, L, Laius, O, Benkö, R, Ziogaite, S, McTaggart, S, Mueller, T, de Pando, T, Tesar, T, Mitkova, Z, Wettermark, B. Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability. BIODRUGS. 2025; 39(5)DOI:10.1007/s40259-025-00732-2. PMID:40779010. IF:6.900(Q1/1D).
01/09/2025
Dimensions of insight in eating disorders: clinical and psychological predictors
Gawron, LP, Garrido-Ribas, I, Amaro-Carriba, MA, Hernández-Molina, M, Carceller-Sindreu, M, Carmona-Farrés, C, Portella, MJ, Pousa, E. Dimensions of insight in eating disorders: clinical and psychological predictors. PSYCHIATRY RESEARCH. 2025; 351DOI:10.1016/j.psychres.2025.116566. PMID:40482577. IF:3.900(Q1/2D).